Search

Zoetis Inc

Slēgts

SektorsVeselības aprūpe

77.09 -0.81

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

76.4

Max

78.11

Galvenie mērījumi

By Trading Economics

Ienākumi

90M

691M

Pārdošana

206M

2.5B

P/E

Sektora vidējais

12.041

57.371

EPS

1.87

Dividenžu ienesīgums

2.79

Peļņas marža

27.998

Darbinieki

14,500

EBITDA

-12M

927M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+15.79% upside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

2.79%

2.23%

Nākamie ieņēmumi

2026. g. 3. nov.

Nākamais dividenžu datums

2026. g. 1. sept.

Nākamais Ex dividenžu datums

2026. g. 30. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-2.2B

30B

Iepriekšējā atvēršanas cena

77.9

Iepriekšējā slēgšanas cena

77.09

Ziņu noskaņojums

By Acuity

57%

43%

289 / 340 Rangs Healthcare

Zoetis Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. aug. 18:21 UTC

Social Media

Zoetis Inc shares are lower today amid challenges in the animal health sector, including tighter regulations and economic pressures affecting consumer spending.

2026. g. 21. aug. 23:36 UTC

Zoetis Inc. shares rose in after-market trading, reflecting a gain since Friday's close and remaining above the 20-day moving average.

2026. g. 20. aug. 23:06 UTC

Zoetis Inc. shares are trading higher in after-market hours, maintaining a routine price action within the middle of their one-month trading range.

2026. g. 19. aug. 23:01 UTC

Zoetis Inc shares are higher in after-market trading, recovering from earlier losses. The stock shows notable strength as it approaches the upper end of its trading range.

2026. g. 18. aug. 23:01 UTC

Zoetis Inc. shares rose slightly in after-market trading, despite remaining below the 20-day moving average and near the lower end of their one-month range.

2026. g. 17. aug. 23:36 UTC

Zoetis Inc shares are lower in after-market hours, following a broader market trend amid rising crude oil prices and geopolitical tensions.

2026. g. 14. aug. 23:06 UTC

Zoetis Inc. shares are higher in after-market trading, recovering from earlier losses. This movement occurs amid broader economic concerns over declining U.S. retail sales.

2026. g. 13. aug. 23:06 UTC

Zoetis Inc. shares moved lower in after-market trading, reflecting a modest decline since Thursday's close. The performance remains within the one-month trading range.

2026. g. 12. aug. 20:01 UTC

News

Zoetis Inc. shares are lower as analysts cut price targets amid broader market pressures. Piper Sandler lowered its target from $90 to $80.

2026. g. 11. aug. 23:36 UTC

Zoetis Inc. shares traded roughly flat in after-market hours, showing minimal change and stability within the middle of its one-month trading range.

2026. g. 10. aug. 23:06 UTC

Correlated Moves
News

Shares of Zoetis Inc. are higher in after-market trading as investor Michael Burry increases his long equity position, citing potential for multi-year stabilization.

2026. g. 8. aug. 00:01 UTC

Zoetis Inc. shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics influenced by recent economic data.

2026. g. 7. aug. 23:01 UTC

Zoetis shares advanced in after-market trading, showing notable activity despite being below the 20-day moving average and near the lower end of its one-month range.

2026. g. 6. aug. 23:26 UTC

News

Zoetis Inc shows a modest advance in after-market trading, now valued at approximately $31.19 billion, ranking as the 298th largest firm by market capitalization.

2026. g. 5. aug. 23:41 UTC

Zoetis Inc. shares declined in after-market trading, remaining below their 20-day moving average despite earlier gains. Asian markets, including the Nikkei 225, performed positively.

2026. g. 4. aug. 19:26 UTC

Zoetis Inc shares are lower today amid unusual volatility, reaching a session low earlier. No specific news was identified to explain the movement.

2026. g. 3. aug. 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

2026. g. 1. aug. 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

2026. g. 31. jūl. 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

2026. g. 30. jūl. 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

2026. g. 29. jūl. 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

2026. g. 28. jūl. 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

2026. g. 27. jūl. 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

2026. g. 25. jūl. 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

2026. g. 24. jūl. 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

2026. g. 23. jūl. 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

2026. g. 22. jūl. 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

2026. g. 21. jūl. 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

2026. g. 20. jūl. 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Salīdzinājums

Cenas izmaiņa

Zoetis Inc Prognoze

Cenas mērķis

By TipRanks

15.79% augšup

Prognoze 12 mēnešiem

Vidējais 90 USD  15.79%

Augstākais 115 USD

Zemākais 80 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Zoetis Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

12 ratings

5

Pirkt

7

Turēt

0

Pārdot

Noskaņojums

By Acuity

289 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat